As of 2025-05-15, the Intrinsic Value of Unichem Laboratories Ltd (UNICHEMLAB.NS) is 409.51 INR. This UNICHEMLAB.NS valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 573.05 INR, the upside of Unichem Laboratories Ltd is -28.50%.
The range of the Intrinsic Value is 366.58 - 459.35 INR
Based on its market price of 573.05 INR and our intrinsic valuation, Unichem Laboratories Ltd (UNICHEMLAB.NS) is overvalued by 28.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (96.80) - (78.82) | (85.98) | -115.0% |
| DCF (Growth 10y) | (48.28) - (45.49) | (47.25) | -108.2% |
| DCF (EBITDA 5y) | 366.58 - 459.35 | 409.51 | -28.5% |
| DCF (EBITDA 10y) | 284.28 - 411.20 | 341.55 | -40.4% |
| Fair Value | -22.52 - -22.52 | -22.52 | -103.93% |
| P/E | (108.37) - (112.87) | (115.53) | -120.2% |
| EV/EBITDA | 200.50 - 646.47 | 419.28 | -26.8% |
| EPV | (49.02) - (55.78) | (52.40) | -109.1% |
| DDM - Stable | (21.37) - (40.86) | (31.12) | -105.4% |
| DDM - Multi | 45.28 - 67.91 | 54.39 | -90.5% |
| Market Cap (mil) | 40,348.45 |
| Beta | 1.11 |
| Outstanding shares (mil) | 70.41 |
| Enterprise Value (mil) | 41,369.15 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.34% |
| Cost of Debt | 6.23% |
| WACC | 15.65% |